Royal Bank of Canada’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.54M | Sell |
|
|||||
|
2025
Q2 | $4.63M | Sell |
|
|||||
|
2025
Q1 | $5.18M | Buy |
|
|||||
|
2024
Q4 | $3.2M | Sell |
|
|||||
|
2024
Q3 | $3.16M | Buy |
|
|||||
|
2024
Q2 | $1.14M | Buy |
|
|||||
|
2024
Q1 | $1.05M | Sell |
|
|||||
|
2023
Q4 | $1.51M | Buy |
|
|||||
|
2023
Q3 | $902K | Sell |
|
|||||
|
2023
Q2 | $1.2M | Buy |
|
|||||
|
2023
Q1 | $1.37M | Sell |
|
|||||
|
2022
Q4 | $1.64M | Buy |
|
|||||
|
2022
Q3 | $622K | Buy |
|
|||||
|
2022
Q2 | $297K | Sell |
|
|||||
|
2022
Q1 | $394K | Sell |
|
|||||
|
2021
Q4 | $410K | Buy |
|
|||||
|
2021
Q3 | $269K | Sell |
|
|||||
|
2021
Q2 | $855K | Buy |
|
|||||
|
2021
Q1 | $200K | Buy |
|
|||||
|
2020
Q4 | $142K | Sell |
|
|||||
|
2020
Q3 | $245K | Sell |
|
|||||
|
2020
Q2 | $384K | Sell |
|
|||||
|
2020
Q1 | $322K | Buy |
|
|||||
|
2019
Q4 | $309K | Sell |
|
|||||
|
2019
Q3 | $440K | Sell |
|
|||||
|
2019
Q2 | $347K | Sell |
|
|||||
|
2019
Q1 | $842K | Sell |
|
|||||
|
2018
Q4 | $317K | Sell |
|
|||||
|
2018
Q3 | $632K | Buy |
|
|||||
|
2018
Q2 | $516K | Buy |
|
|||||
|
2018
Q1 | $394K | Sell |
|
|||||
|
2017
Q4 | $647K | Sell |
|
|||||
|
2017
Q3 | $432K | Buy |
|
|||||
|
2017
Q2 | $455K | Buy |
|
|||||
|
2017
Q1 | $322K | Sell |
|
|||||
|
2016
Q4 | $174K | Sell |
|
|||||
|
2016
Q3 | $257K | Buy |
|
|||||
|
2016
Q2 | $117K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $11K | Sell |
|
|||||
|
2015
Q2 | $19K | Buy |
|
|||||
|
2015
Q1 | $7K | Sell |
|
|||||
|
2014
Q4 | $6K | Hold |
|
|||||
|
2014
Q3 | $7K | Hold |
|
|||||
|
2014
Q2 | $5K | Sell |
|
|||||
|
2014
Q1 | $5K | Buy |
|
|||||
|
2013
Q4 | $4K | Hold |
|
|||||
|
2013
Q3 | $6K | Hold |
|
|||||
|
2013
Q2 | $2K | Buy |
|